|
Market Closed -
NYSE
16:00:03 2026-11-02 EST
|
5-day change | 1st Jan Change | ||
| 337.84 USD | +2.12% |
|
+2.38% | +0.03% |
| 10-21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 10-21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
Company Valuation: Cencora, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 24,820 | 28,048 | 36,148 | 44,117 | 60,593 | 64,469 | - | - |
| Change | - | 13.01% | 28.88% | 22.05% | 37.34% | 6.4% | - | - |
| Enterprise Value (EV) 1 | 28,957 | 30,363 | 38,343 | 45,373 | 63,897 | 71,888 | 70,415 | 69,734 |
| Change | - | 4.86% | 26.28% | 18.33% | 40.83% | 12.5% | -2.05% | -0.97% |
| P/E | 16.2x | 16.8x | 21.1x | 29.9x | 39.3x | 17.9x | 20.4x | 18.4x |
| PBR | 111x | 401x | 54.2x | 67.9x | 34.7x | 17.9x | 11.8x | 9.08x |
| PEG | - | 1.91x | 3.46x | -2.6x | 6.88x | 0x | -1.7x | 1.6x |
| Capitalization / Revenue | 0.12x | 0.12x | 0.14x | 0.15x | 0.19x | 0.19x | 0.18x | 0.18x |
| EV / Revenue | 0.14x | 0.13x | 0.15x | 0.15x | 0.2x | 0.21x | 0.2x | 0.19x |
| EV / EBITDA | 9.73x | 8.55x | 10.4x | 11.1x | 13.5x | 13.4x | 12.5x | 11.4x |
| EV / EBIT | 10.9x | 9.6x | 11.7x | 12.4x | 15.1x | 15x | 13.9x | 12.8x |
| EV / FCF | 13x | 13.8x | 11.1x | 15.1x | 19.9x | 24.7x | 22.2x | 18.2x |
| FCF Yield | 7.7% | 7.27% | 9.01% | 6.61% | 5.02% | 4.05% | 4.5% | 5.5% |
| Dividend per Share 2 | 1.78 | 1.84 | 1.94 | 2.04 | 2.2 | 2.377 | 2.434 | 2.533 |
| Rate of return | 1.49% | 1.36% | 1.08% | 0.91% | 0.7% | 0.7% | 0.72% | 0.75% |
| EPS 2 | 7.39 | 8.04 | 8.53 | 7.53 | 7.96 | 18.85 | 16.52 | 18.41 |
| Distribution rate | 24.1% | 22.9% | 22.7% | 27.1% | 27.6% | 12.6% | 14.7% | 13.8% |
| Net sales 1 | 213,989 | 238,587 | 262,173 | 293,959 | 321,333 | 337,031 | 351,682 | 368,019 |
| EBITDA 1 | 2,977 | 3,553 | 3,702 | 4,080 | 4,721 | 5,373 | 5,630 | 6,091 |
| EBIT 1 | 2,648 | 3,163 | 3,289 | 3,648 | 4,223 | 4,803 | 5,072 | 5,467 |
| Net income 1 | 1,540 | 1,699 | 1,745 | 1,509 | 1,554 | 3,580 | 2,845 | 3,164 |
| Net Debt 1 | 4,137 | 2,315 | 2,195 | 1,255 | 3,305 | 7,418 | 5,946 | 5,265 |
| Reference price 2 | 119.45 | 135.33 | 179.97 | 225.08 | 312.53 | 337.84 | 337.84 | 337.84 |
| Nbr of stocks (in thousands) | 207,787 | 207,258 | 200,854 | 196,008 | 193,878 | 190,827 | - | - |
| Announcement Date | 11/4/21 | 11/3/22 | 11/2/23 | 11/6/24 | 11/5/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.55x | 0.21x | 13.13x | 0.72% | 64.47B | |
| 35.13x | 4.15x | 15.59x | 2.44% | 191B | |
| 20.76x | 3.57x | 12.79x | 2.94% | 122B | |
| 25.05x | 4.5x | 15.4x | 1.24% | 117B | |
| 32.34x | 3.11x | 12.55x | 2.2% | 96.21B | |
| 31.56x | 7.87x | 20.09x | 1.28% | 52.51B | |
| 40.33x | 3.62x | 12.32x | 2.11% | 54.1B | |
| 37.34x | 9.27x | 25.93x | -.--% | 52.91B | |
| 44.54x | 3.36x | 12.49x | 0.52% | 35.65B | |
| 32.32x | 5.8x | 18.18x | -.--% | 31.61B | |
| Average | 31.69x | 4.55x | 15.85x | 1.35% | 81.64B | |
| Weighted average by Cap. | 30.39x | 4.25x | 15.30x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- COR Stock
- Valuation Cencora, Inc.
Select your edition
All financial news and data tailored to specific country editions
